Correlation between MSI, TMB, and TGFBR2 gene mutation in solid tumors.

被引:0
|
作者
Fan, Xinglong
Hu, Huimin
Cao, Yufeng
Xuan, Tiantian
Xin, Jianjun
Gao, Qiangfang
Ma, Juan
Wang, Chenxi
Ding, Ran
Bu, Fanfeng
机构
[1] Shandong Univ QingDao, Qilu Hosp, Qingdao, Peoples R China
[2] Jiangsu Simcere Diagnost Co, Nanjing, Peoples R China
[3] Qingdao Univ, Affiliated Qingdao Hiser Hosp, Qingdao, Peoples R China
[4] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Qingdao, Peoples R China
[5] Qingdao Cent Hosp, Qingdao, Peoples R China
[6] Qingdao Univ, Peoples Hosp 3, Qingdao, Peoples R China
[7] Nanjing Simcere Med Lab Sci Co Ltd, Nanjing, Peoples R China
[8] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14558
引用
收藏
页数:1
相关论文
共 50 条
  • [21] TGFBR2 mutation analysis in Marfanoid patients with ascending aortic aneurysm
    Arno, Gavin
    Comeglio, P.
    Hasso, S.
    Child, A. H.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S79 - S79
  • [22] TGFBR2 Gene Mutational Spectrum in Aortic Pathology Reply
    Siu, Samuel C.
    Silversides, Candice K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (04) : 519 - 519
  • [23] Treatment of a patient with vertebral and subclavian aneurysms in the setting of a TGFBR2 mutation
    Sylvan, Joshua
    Greenberg, Roy K.
    Mastracci, Tara M.
    Eagleton, Matthew J.
    Moran, Rocio
    JOURNAL OF VASCULAR SURGERY, 2013, 57 (04) : 1116 - 1119
  • [24] Evidence of correlation between TGFBR2 gene expression mediated by NF-κb signaling pathways and Kawasaki disease in children
    Gao, Qinling
    Yuan, Shuhua
    Yuan, Dawei
    MINERVA PEDIATRICA, 2018, 70 (05) : 438 - 443
  • [25] Genomic profiles of chromosome remodeling pathway and their correlation with TMB, MSI, PD-L1, and immune microenvironment in biliary tract tumors.
    Shen, Ningjia
    Shi, Xintong
    Zhang, Yongjie
    Zhong, Xuefeng
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Identification of TGFBR2 mutation as a negative predictor of immunotherapy in NSCLC.
    Li, Teng
    Wang, Han
    Xu, Jiachen
    Li, Chengcheng
    Zhang, Yudong
    Wang, Guoqiang
    Cai, Shangli
    Li Junling
    Wang, Zhijie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] PD1 X TGFBR2 AND CD5 X TGFBR2 BISPECIFICS SELECTIVELY BLOCK TGFBR2 ON TARGET-POSITIVE T CELLS, PROMOTE T CELL ACTIVATION, AND ELICIT AN ANTI-TUMOR RESPONSE IN SOLID TUMORS
    Moore, Gregory
    Schubbert, Suzanne
    Bonzon, Christine
    Avery, Kendra
    Rashid, Rumana
    Pong, Erik
    Ochyl, Lukasz
    Nisthal, Alex
    Chu, Seung
    Ernst, James
    Desjarlais, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A913 - A913
  • [28] A TURKISH PATIENT OF TYPICAL LOEYS-DIETZ SYNDROME WITH A TGFBR2 MUTATION
    Tug, E.
    Loeys, B.
    De Paepe, A.
    Aydin, H.
    Gideroglu, K.
    GENETIC COUNSELING, 2010, 21 (02): : 225 - 232
  • [29] Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2
    van Steensel, Maurice A. M.
    van Geel, Michel
    Parren, Lizelotte J. M. T.
    Schrander-Stumpel, Constance T. R. M.
    Marcus-Soekarman, Dominique
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (04) : 362 - 365
  • [30] Association between TGFBR2 gene polymorphisms and congenital heart defects in Han Chinese population
    Huang, Fuhua
    Li, Li
    Shen, Chong
    Wang, Hairu
    Chen, Jinfeng
    Chen, Wen
    Chen, Xin
    NUTRICION HOSPITALARIA, 2015, 31 (02) : 710 - 715